CCR5 in T cell-mediated liver diseases: what's going on?
The chemokine receptor CCR5 came into worldwide prominence a decade ago when it was identified as one of the major coreceptors for HIV infectivity. However, subsequent studies suggested an important modulatory role for CCR5 in the inflammatory response. Specifically, CCR5 has been reported to directly regulate T cell function in autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, and type 1 diabetes. Moreover, T cell-mediated immune responses are proposed to be critical in the pathogenesis of autoimmune and viral liver diseases, and recent clinical and experimental studies have also implicated CCR5 in the pathogenesis of autoimmune and viral liver diseases. Therefore, in this brief review, we highlight the evidence that supports an important role of CCR5 in the pathophysiology of T cell-mediated liver diseases with specific emphasis on autoimmune and viral liver diseases.
Ajuebor
Maureen N
MN
Gastrointestinal Research Group, Faculty of Medicine, University of Calgary, 3330 Hospital Drive Northwest, Calgary, Alberta, Canada.
Carey
Jillian A
JA
Swain
Mark G
MG
D000818:Animals; D019693:Hepatitis, Autoimmune / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology; D006524:Hepatitis, Viral, Animal / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology; D006525:Hepatitis, Viral, Human / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008107:Liver Diseases / Q000276:immunology* / Q000378:metabolism* / Q000503:physiopathology; D019713:Receptors, CCR5 / Q000502:physiology*; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism* / Q000473:pathology
D019713:Receptors, CCR5